| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304376C Method for preparing ion liquid in halogenated alkyl imidazole type |
| 03/14/2007 | CN1304001C Nitroimidazole external preparations for dermatosis |
| 03/13/2007 | US7189865 Thiomolybdate analogues and uses thereof |
| 03/13/2007 | US7189859 Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189748 Compounds and methods for treating insulin resistance and cardiomyopathy |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
| 03/13/2007 | US7189702 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 03/13/2007 | US7189519 Identifying bound modified g-protein coupled receptors assemblies; microarrays; drug screening; colorimetric analysis |
| 03/13/2007 | US7189268 Using an 2-azoimidazole compound; dyeing human hair |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/08/2007 | WO2007026766A1 1,3-diiodohydantoin compound and process for production thereof |
| 03/08/2007 | WO2007025575A1 O-hydroxy- and o-amino benzamide derivatives as ikk2 inhibitors |
| 03/08/2007 | WO2007025434A1 A new compound, preparation process and use therrof |
| 03/08/2007 | US20070055459 Structure-based approach to design of protein-processivity factor interactions |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
| 03/08/2007 | US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/07/2007 | EP1758868A1 Novel cis-imidazolines |
| 03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
| 03/07/2007 | EP1758847A1 Inhibitors of histone deacetylase |
| 03/07/2007 | CN1926116A Method for the production of compounds with quaternary sp<2>-hybridised nitrogen atoms |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1923817A Preparation method for optical enantiomer of ornidaxole |
| 03/07/2007 | CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 03/07/2007 | CN1923781A Method of synthesizing compound containing difluoromethyl group |
| 03/07/2007 | CN1303070C Compound possessing fungicidal property and its usage for preventing and treating plant disease |
| 03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/06/2007 | CA1341521C 1-hydroxyethyl-azole derivatives, a process for their preparation and their use as plant growth regulators and fungicides |
| 03/01/2007 | WO2007025271A1 Method of making imidazole-2-ones and 2-thiones |
| 03/01/2007 | WO2007023877A1 Remedy for corneal diseases |
| 03/01/2007 | WO2007023822A1 Method for producing 1-substituted-5-acylimidazole compound |
| 03/01/2007 | WO2007022947A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2006119713A3 Antineoplastic compounds and pharmaceutical compositions thereof |
| 03/01/2007 | WO2006098969A3 Quinazolinone t-type calcium channel antagonists |
| 03/01/2007 | US20070049623 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections |
| 03/01/2007 | CA2619731A1 Process for preparing 1-substituted 5-acylimidazole compounds |
| 02/28/2007 | EP1757591A1 Cinnamide compound |
| 02/28/2007 | EP1757579A1 Primary 2,6-disubstituted para-phenylenediamines and their uses for dyeing keratin fibres |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756089A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/28/2007 | EP1756085A1 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
| 02/28/2007 | EP1756066A1 Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity |
| 02/28/2007 | EP1756065A1 Anti-cytokine heterocyclic compounds |
| 02/28/2007 | EP1755613A2 Substituted cyclic urea derivatives |
| 02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | CN1922154A Method of manufacturing 4-nitroimidazole compound |
| 02/28/2007 | CN1922153A Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5-dimethylbenzoic acid or ester thereof |
| 02/28/2007 | CN1922152A Novel imidazolium compound |
| 02/28/2007 | CN1922151A Substituted azole derivatives, compositions, and methods of use |
| 02/28/2007 | CN1922147A Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor |
| 02/28/2007 | CN1919841A Synthetic intermediate of Irbesartan, preparation method and use thereof |
| 02/28/2007 | CN1302116C Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 02/28/2007 | CN1302002C Hydroxylamine esters as polymerization initiators |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/28/2007 | CN1301963C Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll |
| 02/27/2007 | US7183410 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin) useful for treating psychological and nerveous system disorders |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183305 Reaction of cyano compound with silylalkylisocyanide for active imidazoles |
| 02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/22/2007 | WO2007022173A2 Crystalline forms fenoldopam mesylate |
| 02/22/2007 | WO2007021877A1 Imidazole compounds that modulate hsp90 activity |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2007019937A1 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| 02/22/2007 | WO2007019660A2 Azole compounds used as tuberculostatic and leishmanicide agents |
| 02/22/2007 | US20070043512 Therapeutic and prophylactic compositions and uses therefor |
| 02/22/2007 | US20070043220 {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid; diabetes mellitus, Metabolic Syndrome, atherosclerosis, cardiovascular diseases,Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension |
| 02/22/2007 | US20070043093 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 02/22/2007 | US20070043084 1,2-Diarylimidazoles useful as inhibitors of cox |
| 02/22/2007 | US20070043035 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 02/22/2007 | US20070043007 Specific glucocorticosteroid compounds having anti-inflammatory activity |
| 02/22/2007 | CA2618747A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | CA2618724A1 Imidazole compounds that modulate hsp90 activity |
| 02/22/2007 | CA2617378A1 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| 02/22/2007 | CA2613465A1 Crystalline forms fenoldopam mesylate |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1753758A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/21/2007 | EP1753729A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides |
| 02/21/2007 | EP1753728A1 Phenylnaphthylimidazoles for use on copper surfaces during soldering |
| 02/21/2007 | EP1753727A1 Novel cis-imidazolines |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1361851B1 Primary intermediates for oxidative coloration of hair |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP1254075B1 Nonaborate compositions and their preparation |
| 02/21/2007 | EP1000025B1 Substituted naphthopyrans |
| 02/21/2007 | CN1918132A Method of coloring with capped diazotized compound and coupling component |
| 02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
| 02/21/2007 | CN1918130A Method for the production of n,n -carbonyldiazoles |